Prostate Cancer Clinical Trials Consortium Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Prostate Cancer Clinical Trials Consortium's estimated annual revenue is currently $10.7M per year.(i)
  • Prostate Cancer Clinical Trials Consortium's estimated revenue per employee is $201,000

Employee Data

  • Prostate Cancer Clinical Trials Consortium has 53 Employees.(i)
  • Prostate Cancer Clinical Trials Consortium grew their employee count by 18% last year.

Prostate Cancer Clinical Trials Consortium's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.3M617%N/AN/A
#2
$354.3M461-2%$567.1MN/A
#3
$377.1M1876-1%N/AN/A
#4
$7.8M398%N/AN/A
#5
$5.4M270%N/AN/A
#6
$45M2246%N/AN/A
#7
$6.8M34-82%N/AN/A
#8
$9.2M4612%N/AN/A
#9
N/A69446%N/AN/A
#10
$15.5M775%N/AN/A
Add Company

What Is Prostate Cancer Clinical Trials Consortium?

The PCCTC’s distinguished investigators work together on a single mission: to design, implement and complete hypothesis-driven early phase trials in prostate cancer, translating scientific discoveries to improved standards of care. We offer services to carry out this mission ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.

keywords:N/A

N/A

Total Funding

53

Number of Employees

$10.7M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.9M53-7%N/A
#2
$6.7M53-13%N/A
#3
$10.5M532%N/A
#4
$12.1M534%N/A
#5
$7.2M53-4%N/A